Drug Profile
Rogletimide
Alternative Names: PyridoglutethimideLatest Information Update: 13 Aug 2002
Price :
$50
*
At a glance
- Originator Unknown
- Developer Schering-Plough; Unknown
- Class Antineoplastics; Hormones
- Mechanism of Action Aromatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer